Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- Your extralabel use of an approved human or animal drug caused a residue above an established safe level, safe concentration, or tolerance.
- You administered a prohibited drug in an extralabel manner to food-producing animal(s).
- You did not keep and maintain complete treatment records.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Bradley M. Burton | Veterinary | 12/06/2023 | ELDU - producer causes Illegal drug residue |
| Bradley M. Burton | Veterinary | 12/06/2023 | Drugs prohibited for extralabel use in food-producing animal(s) |
| Bradley M. Burton | Veterinary | 12/06/2023 | Record keeping |
Alerts Sign-up